The BSE Sensex and NSE Nifty ended in green on Wednesday on account of firm global markets. Sensex closed 438.12 points up at 25,338.58, while Nifty settled 138.20 points up at 7,735.20.
Below are 7 stocks that remained in news today:
Rallis India: Shares of agro-chemical firm Rallis India rose by over 5 per cent intraday on Wednesday after the Tata group’s agri-input arm entered into an agreement with IKEA India to transfer its leasehold right over a land parcel here for nearly Rs 214 crore. The scrip closed 1.88 per cent up at Rs 173.
Adani Transmission: Rating agencies Standard & Poor’s and Fitch have assigned investment grade ‘BBB-‘ corporate credit rating with stable outlook to Adani Transmission. The share price of Adani Transmission settled 4.70 per cent up at Rs 34.50.
HealthCare Global Enterprises: HealthCare Global Enterprises (HCG) made a weak debut on bourses on Monday as shares the cancer-care network operator listed at Rs 209.80 on BSE against the issue price of Rs 218. The share price of HealthCare Global slipped 21.58 per cent to Rs 170.95 on BSE. The scrip plunged 19.01 per cent to Rs 170.25 on NSE. READ MORE
Tata Steel: The company is considering the sale of its entire UK business to stem heavy losses, a move that would draw a line under its almost decade-long foray into Britain’s declining steel industry. The scrip closed 6.75 per cent up at Rs 324.40 on BSE.
Union Bank of India: Public sector Union Bank of India on Tuesday said it has raised Rs 1,000 crore by issuing bonds on private placement basis. Shares of the bank ended the day at Rs 129.05, up 3.57 per cent against their previous close.
Sun Pharma: Drug major Sun Pharma has forayed into the Japanese prescription market by acquiring 14 brands from Swiss drug firm Novartis for $293 million (over Rs 1,940 crore). Shares of Sun Pharma closed 2.21 per cent up at Rs 811.60.
Aurobindo Pharma: Aurobindo Pharma has received final approval from the USFDA to manufacture and market Vancomycin Hydrochloride for Injection USP, 5 g/vial and 10 g/vial (Pharmacy Bulk Package). This product is expected to be launched in the later part of FY16-17. Shares of Aurobindo Pharma closed 0.86 per cent up at Rs 741.70.
(With agency inputs)